337 related articles for article (PubMed ID: 23128977)
21. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
22. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
[TBL] [Abstract][Full Text] [Related]
24. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
[TBL] [Abstract][Full Text] [Related]
27. Influence of HPV16 E6/7 on the expression of FGF2 and FGFR type B in cervical carcinogenesis.
Cheng YM; Chou CY; Hsu YC; Chen MJ
Reprod Sci; 2012 Jun; 19(6):580-6. PubMed ID: 22421447
[TBL] [Abstract][Full Text] [Related]
28. Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation.
Gutierrez-Xicotencatl L; Pedroza-Saavedra A; Chihu-Amparan L; Salazar-Piña A; Maldonado-Gama M; Esquivel-Guadarrama F
Mol Cancer Res; 2021 Feb; 19(2):167-179. PubMed ID: 33106372
[TBL] [Abstract][Full Text] [Related]
29. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
31. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
Chen B; Zhao L; Yang R; Xu T
Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
Han MS; Lee JM; Kim SN; Kim JH; Kim HS
Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
[TBL] [Abstract][Full Text] [Related]
33. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
34. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
[TBL] [Abstract][Full Text] [Related]
35. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
36. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
37. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of HPV16 E6 oncogene in cervical cancer by RNA interference].
Niu XY; Peng ZL; Duan WQ; Wang H; Chen YY; Fan YJ; Cheng YF; Qian XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):14-8. PubMed ID: 16468632
[TBL] [Abstract][Full Text] [Related]
39. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
Luczak MW; Jagodzinski PP
Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
[TBL] [Abstract][Full Text] [Related]
40. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
